Ann: Clinical Milestone - 100 patients treated with DurAVR THV, page-14

I accept the consolation (it’s just cosmetic). I supported the move to Nasdaq. I appreciate the need to raise capital to do anything meaningful. I’m not happy about the pace they operate at ( small businesses are supposed to agile and efficient). I’m not happpy about the rate they spend money and seem to have nothing to show for it ( this last year as an example) and as I’ve said repeatedly here, Patto’s interests are not aligned with shareholders. Massive amount of long term options and I have no idea what he has to do to earn them because I’m not seeing anything other than another CR. Seems to be a “death spiral” where people are selling because they think they can buy back cheaper before significant progress is made. We need an entrepreneur.